RATIONALE FOR RETIREMENT
The 2007 AAN guideline “Neutralizing antibodies to interferon beta: Assessment of their clinical and radiographic impact: An evidence report” was retired by the Guideline Subcommittee of the AAN Institute on January 26, 2019. The AAN does not have resources to update the Guideline.
Letters: Rapid online correspondence
- Neutralizing antibodies to interferon beta: Assessment of their clinical and radiographic impact
- Reply from the author to Sorensen and Bertolotto
- Neutralizing antibodies to interferon beta: Assessment of their clinical and radiographic impact:
- Reply from the author to Polman et al
- Neutralizing antibodies to interferon beta: Assessment of their clinical and radiographic impact
- Reply from the author to Pachner
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
